Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2010 May;87(5):558-62.
doi: 10.1038/clpt.2009.232. Epub 2010 Feb 3.

ABCG2 polymorphism is associated with the low-density lipoprotein cholesterol response to rosuvastatin

B Tomlinson  1 , M Hu, V W Y Lee, S S H Lui, T T W Chu, E W M Poon, G T C Ko, L Baum, L S Tam, E K Li
Affiliations
Randomized Controlled Trial

ABCG2 polymorphism is associated with the low-density lipoprotein cholesterol response to rosuvastatin

B Tomlinson et al. Clin Pharmacol Ther. 2010 May.

Abstract

The ATP-binding cassette G2 (ABCG2) c.421C>A (rs2231142) polymorphism influences the pharmacokinetics of rosuvastatin. We examined whether this polymorphism influences the low-density lipoprotein cholesterol (LDL-C)-lowering efficacy of the drug. In 305 Chinese patients with hypercholesterolemia who were treated with rosuvastatin at a dosage of 10 mg daily, the c.421A variant was found to be significantly associated with greater reduction in LDL-C level, in a gene-dose-dependent manner. As compared with subjects with the c.421CC genotype, those with the c.421AA genotype showed a 6.9% greater reduction in LDL-C level, which would be equivalent to the effect obtained by doubling the dose of rosuvastatin.

PubMed Disclaimer

Publication types

MeSH terms